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Summary. The distribution of muscarinic acetylcholine r - 
ceptor protein (mAChR) in the rat forebrain and upper 
brainstem was described by using a monoclonal antibody 
(M35) raised against mAChR purified from bovine fore- 
brain homogenates. A method is investigated for light mi- 
croscopic (LM) and electronmicroscopic (EM) immunocy- 
tochemical visualization of reactivity to mAChR-proteins. 
Putative cholinoceptive neurons including their dendrites 
were found immunoreactive in the cortical mantle, hippo- 
campus, basal ganglia, amygdala, thalamus and several 
midbrain regions. In the neocortex, immunoprecipitate with 
M35 was mainly present in layer 5 pyramidal cells, some 
layer 3 pyramidal neurons and layer 2 stellate cells, all in- 
cluding their characteristic dendritic profiles of both basal 
and apical dendrites. In the hippocampus, a variety of pyra- 
midal, granular and non-pyramidal celltypes were stained 
in various hippocampal cell layers, in the dentate hilus and 
in stratum oriens of cornu ammonis. Moreover, positively 
reacting cells occurred in central and lateral amygdala, all 
parts of the basal ganglia and ventral pallidum. The thala- 
mus was very richly provided with labeled neurons in sever- 
al nuclei but notably numerous in the ventrolateral, antero- 
ventral and geniculate nuclei. In cortex and hippocampus 
also some staining of astrocytes occurred. Electron micro- 
scopic study of the intracellular distribution of M35 immu- 
noreactivity in all cases showed dense precipitates in the 
soma cytoplasm in close association with the golgi appara- 
tus, but conspicuous absence near the endoplasmic reticu- 
lure. Immunoprecipitate can be followed within the den- 
dritic tree along the microtubular transport system, up to 
proximal and distal postsynaptic membrane positions, ap- 
posing non labeled presynaptic endings. Muscarinic recep- 
tor subtype recognition by M35 will be discussed by com- 
paring M35 distribution with cholinergic innervation pat- 
terns, muscarinic receptor ligand binding studies and local- 
ization of muscarinic receptor subtype mRNAs. 
Introduction 
The study of identification of neuronal networks has under- 
gone an impressive development asa result of the introduc- 
tion of immunohistochemical and immunocytochemical 
methods. By means of polyclonal and monoclonal anti- 
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bodies directed against chemical neuroactive compounds, 
essentially any molecular structure related to neuronal ele- 
ments can be demonstrated once a specific antibody is avail- 
able. Applications have included the chemical definition of 
structural neuronal elements, neuroactive proteins, neu- 
rotransmitters, neuropeptides, transmitter-related enzymes 
and so forth. A more recent application of immunocyto- 
chemistry to the study of neural systems relates to the neu- 
ronal receptors involved in chemical neurotransmission. 
Traditionally, the demonstration f neurotransmitter r - 
ceptors has been the domain of neuropharmacology. The 
most widely used approach for detection and characteriza- 
tion of receptor proteins has been competitive and non- 
competitive binding studies using either synthetic molecules 
or the native neurotransmitter as an agonist (Kellar et al. 
1985; Kuhar and Yamamura 1976; Rotter etal. 1979; 
Wamsley et al. 1981). Although receptor binding autoradi- 
ography may remain the method of choice for pharmaco- 
logical applications, the autoradiographic technique holds 
several serious limitations for the neuroanatomical study 
of receptor localization, due to the relatively poor resolu- 
tion at the light microscopic level. Quantitative measures 
of binding to receptor can be established for cellular egions 
or layers but only rarely in association with individual neu- 
ronal elements. Detection of tritiated receptor ligands at 
the electron microscopic level has been reported in some 
studies, but such methods are technically complex, time 
consuming and probably not suitable for routine applica- 
tions. Furthermore, ligands often penetrate poorly in brain 
tissue sections and subsequent visualization of the actual 
subcellular binding sites is hampered by the relatively large 
distances the energy quanta travel in the autoradiographic 
emulsions (Hamel and Beaudet 1987; Kuhar et al. 1981). 
Structural aspects of receptor proteins can now be stud- 
ied on cellular and subcellular levels as a result of the devel- 
opment of successful methods for receptor protein purifica- 
tion and the subsequent production of monoclonal anti- 
bodies to them. Several studies have been recently reported 
on immunocytochemical demonstration f nicotinic acetyl- 
choline receptors (Deutch etal. 1987; Jacob etal. 1986; 
Lentz and Chester 1977; Lindstrom 1986; Nghiem et al. 
1983; Sealock et al. 1984; Swanson et al. 1983), glycine re- 
ceptors (Araki et al. 1988; Triller et al. 1985; Van den Pol 
and Gorcs 1988), fl-adrenergic receptors (Aoki et al. 1987), 
GABA/benzodiazepine r ceptors (Houser et al. 1988; Ri- 
chards et al. 1987) and dopamine receptors (Goldsmith 
et al. 1979). 
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As part of our analysis of basal forebrain cholinergic 
systems we became strongly interested in the subcellular, 
synaptic localization of acetylcholine r ceptors and in the 
distribution of cholinoceptive neurons, tn the present paper 
we report the light- and electron microscopic distribution 
of immunoreactivity to muscarinic acetylcholine receptor 
proteins through the use of a highly specific monoclonal 
antibody raised against bovine forebrain muscarinic recep- 
tor (M35). The focus of the present report is on general 
appearance of the precipitates at LM level and cholinocep- 
tive cell distribution in forebrain and upper brainstem. 
Some major ultrastructural observations on intracellular 
immunoreactivity will be described of which preliminary 
data have been published elsewhere (Luiten et al. 1988; 
Matsuyama et al. 1988). 
Materials and methods 
Fixation condition. Fixation of the brain was carried out by trans- 
cardial perfusion preceeded by a prerinse with 100 ml saline solu- 
tion of 37 ~ C at a perfusion speed of 20 ml/min. The choice of 
fixative depended on whether the tissue was used for light micro- 
scopic (LM) analysis alone or LM followed by further treatment 
for electron microscopic (EM) study. For LM purposes optimal 
results were so far obtained by perfusion with 300 ml (15 ml/min) 
of the Zamboni f xative (Zamboni and DeMartino 1967) composed 
of 2% paraformaldehyde and 0.2% picric acid in phosphate buffer 
(PB) (0.125 M, pH 7.4). In case of subsequent EM analysis, 0.05% 
glutaraldehyde was added to this solution. 
Immediately after the fixation perfusion the fixative was rinsed 
out by a perfusion with 150 ml of 10% sucrose in 0.1 M PB. Pro- 
longed fixation progressively decreases pecific immunostaining 
and should be avoided. Immunostaining was carried out on either 
frozen or vibratome sections. In case of frozen sectioning the brains 
were cryoprotected by overnight storage at 4~ in 30% sucrose 
in 0.1 M PB. For optimal results, vibratome or frozen sections 
were cut at a thickness of 20 gm. 
Immunocytochemical procedure. In order to obtain a high density 
of immunocytochemical st ining against an unstained light back- 
ground level, it is critical to suppress nonspecific antibody binding. 
This was done by repeated and thorough rinsing in phosphate 
buffered saline (PBS) and pretreatment with normal rabbit serum 
(NRS) and carrageenan. 
Prior to the first antibody incubation, sections were rinsed in 
PBS, immersed in0.01% H~Oz in PBS, rinsed again, and incubated 
in 10% NRS and 0.25% carrageenan (Sigma, type IV) in PBS 
for 1 h at room temperature. Thereafter, the sections were incu- 
bated with the first antibody (M35) diluted 1:2000 in 1% NRS 
in PBS for 3 days at 4 ~ C under gentle movement of the incubation 
medium. After incubation the sections were thoroughly rinsed and 
exposed to 0.25% carrageenan in PBS for 1 h, followed by second 
antibody incubation with biotinylated rabbit anti-mouse IgM 
(Zymed) 1:500 in PBS containing 1% NRS overnight at 4~ 
Sections were again rinsed and immersed in 0.25% carrageenan 
in PBS (1 h) before the third incubation step in HRP conjugated 
streptavidin (Zymed) 1:200 in PBS overnight at 4 ~ C. Finally the 
tissue sections were processed by a diaminobenzidine(DAB)-H2Oz 
reaction (30 mg DAB and 0.01% H202/100 ml Tris buffer) for 
at least 4 min, guided by a visual check, and then mounted for 
LM inspection. Vibratome sections for EM study were postfixed 
with subsequent exposure to 1% OsO4 for one hour, dehydrated 
in an ascending series of ethanol, stained en block with 1% uranyl 
acetate in 70% ethanol and flat-embedded in epon. Selected tissue 
blocks were cut to ultrathin sections and investigated in Philips 
201 or 300 electron microscopes. 
Characterization of monoclonal antibody M35. Purification of mus- 
carinic receptor (mAChR) proteins and antibody production have 
been extensively described elsewhere (Andr6 et al. 1983, 1984, 
1987). The monoclonaI ntibody M35 was generated against mus- 
carinic receptor proteins purified from bovine forebrain homoge- 
nates. In short the membrane fractions were soIubilized in a 1% 
digitonin solution in PBS and the solubilized protein solution 
reacted with a dexetimide coupled affinity gel. The muscarinic re- 
ceptor proteins bound to the dexetimide were removed from the 
gel by specific elution with the mAChR antagonists atropine or 
propylbenzilylcholine mustard. The mAChR protein from the 
eluate was characterized as a 70 kDa glycoprotein (Andr6 et al. 
1983). Antibody production started by immunizing BALB/c mice 
with the afffinity-purified mAChR proteins, whereafter the spleen 
cells were fused with a myeloma cell line. Selected clones were 
further propagated in ascites in mice and the monoclonals tested 
for reactivity to radiolabeled purified mAChRs, digitonin solubi- 
lized mAChR and Western blots of solubilized membrane prepara- 
tions. Monoclonal antibody M35 was demonstrated to strongly 
recognize solubilized muscarinic receptor proteins by indirect im- 
munoprecipitation, a d by direct immunoadsorption of mAChR 
to M35 coupled to Sepharose 4B (Andr6 et al. 1984, 1987). Mono- 
clonal antibody M35 was retained after extensive testing proce- 
dures that showed it to yield an agonist-like activity in physiologic 
conditions. M35 mimicked agonist stimulation of the myometrium 
in guinea pig and rat by causing uterine contractions that were 
suppressed by atropine, demonstrating immunoprecipitation of 
M35 to epitopes on mAChRs in rat smooth muscle tissue. That 
the M35 effects are mediated by the mAChR is further indicated 
by an M35-induced increase in cyclic GMP levels, comparable to
that observed after carbachol stimulation (Leiber et al. 1984). Re- 
cently, immunocytochemical demonstration f M35 binding to 
mAChR on human fibroblasts culture was shown to be regulated 
by treatment ofthe culture ceils with the muscarinic agonist carba- 
mylcholine (Raposo et al. 1987). Although there is ample evidence 
that M35 specifically recognizes mAChR proteins (Andr6 et al. 
1984, 1987; Leiber et al. 1984; Raposo et al. 1987), specificity of 
the M35 immunoprecipitate in rat brain sections were only ob- 
tained in an indirect way. We were not able to perform preadsorp- 
tion of the antibody because of the extremely small quantity of 
receptor protein yielded by the purification methods. Nevertheless, 
control experiments were done, e.g. omission of the primary anti- 
body and its substitution by normal mouse serum, or substitution 
of M35 by different non-matching antibodies of the IgM- or IgG- 
class. All failed to show immunoreactivity. Application of M35 
to rat cerebral cortex tissue was previously reported in preliminary 
form (Luiten et al. 1987; Matsuyama etal. 1988). 
Results 
Immunocytochemical application of monoclonai antibody 
M35 under the conditions of fixation and after processing 
as described above yielded a pattern of cellular staining 
of cell bodies including their dendrites in various parts of 
the brain. This immunocytochemical staining pattern, al- 
though clear against low background activity, showed vari- 
ations in staining intensity in different parts of the brain 
and varied from light staining to very dense precipitates. 
Staining generally resulted in rather consistent patterns 
of immunoreactivity, but local variability indicated a high 
level of susceptibility of the antigen to processes of fixation, 
perfusion, freezing and thawing, sectioning and immunocy- 
tochemical procedure steps. Again, some parts of the brain 
(e.g. the thalamus, limbic cortex) appeared to be more sensi- 
tive to procedural variations than others (e.g. neocortex). 
As will be argued below, such variations may reflect the 




Fig. 1 A-E. Photomicrographs of immunoreactive n urons and glia 
to monoclonal antibody M35 against mAChR protein. A and C 
show immunoreactive c ll bodies and their apical and basal den- 
drites of pyramidal cells in layer 5 of fronto-parietal (A) and parie- 
tal motor cortex (C). B Shows an immunolabeted non-pyramidal 
multipolar neuron in layer 2 of the parietal neocortex. D Astrocyte 
immunostained with anti -mAChR antibody M35 in layer 2 of the 
neocortex and usually encountered in the superficial cortical ayers. 
E Large and small labeled cholinoceptive c lls in the caudate-puta- 
men. Scale bar in A -C=25 gin; in D= 10 gm and in E=50 gm 
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LM pattern of M35 immunoprecipitate 
Teleneephalon. The pattern of cellular staining with M35 
in the cortex showed a clear laminar distribution. In most 
of the cortical mantle, especially in the neocortical areas, 
predominantly layer 5 cells revealed strong immunoreactivi- 
ty. Precipitate was found present in the soma cytoplasm 
extending into the basal and apical dendrites to be followed 
up to the branching region in layer 1/2. The labeled layer 
5 cells were non-spinous at least in their LM appearance 
(Figs. 1 A, C and 2). In addition, less numerous immunore- 
active neurons of various types were detected in layers 2 
and 3, and in layer 6. Layer 4 of the neocortex was strikingly 
devoid of precipitate xcept for the apical dendrites of the 
layer 5 pyramidal cells traversing layer 4. In the limbic 
cortex the pattern was less regular and fewer cells of various 
types were labeled (Fig. 1 B), in all layers except layer 1. 
In most layers of the cortex but notably in layers 1-3, as 
well as in the hippocarnpus ome staining of astrocytes 
could be observed (Fig. 1 D). Such staining was found to 
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Fig. 2. Camera lucida drawing of the pattern of immunoreactivity 
to M35 in the fronto-parietal neocortex showing the distribution 
of labeled cell bodies and their dendrites. Note the dominating 
immunolabeling of layer $ pyramidal cells, moderate labeling in 
layers 2, 3 and 6. Astrocytes immunoreactive with M35 are indi- 
cated in layers i and 2. Highest levels of dendrite labeling is present 
in layer 5 (pyramidal cell basal dendrites) and in layers 1 and 
2 (branching layer 5 cell apical dendrites) 
be increased in aging animals and after brain injury as shall 
be dealt with in a separate report. 
Very regular laminar distribution of immunoreactive 
cells was found in the olfactory bulb where the large mitral 
cells including their dendrites were densely stained. Immu- 
nostaining in the hippocampal formation was characterized 
by a pattern of labeled pyramidal cells in cornu ammonis 
fields CA2-CA4, and granular cells in the fascia dentata 
(FD) (Figs, 3B and 4C), besides a scattered group of la- 
beled interneurons in stratum oriens and lacunosum-mole- 
culare of CAI-CA3 (Figs. 3A and 4A, B). Also in the hilar 
region of the FD a considerable number of cells were im- 
munostained with M35 (Fig. 4C). Pyramidal cell labeling 
in the cornu ammonis tend to be more predominant in 
CA2-3 than in CA1. Strongly labeled cells occurred in the 
central amygdala, even exceeding the labeling in the baso- 
lateral amygdala, whereas medial amygdala staining was 
moderate. 
From the basal ganglia, immunoprecipitate in the stria- 
turn showed a differentiated pattern. Darkly stained neu- 
rons were observed mainly in the ventrolateral regions 
(Fig. 1 E). The majority of the striatal cells, however, dis- 
played moderate to light immunoreactivity to M35. Densely 
staining cells were more numerous in the globus pallidus 
and related ventral pallidal regions and substantia innomin- 
ata. Immunoreactivity was considerable in lateral septal nu- 
clei and dorsal cell groups of the medial septum, bed nucle- 
us of the stria terminalis and medial preoptic nucleus. 
Diencephalon. Several nuclei in the thalamus revealed is- 
tinct staining of large numbers of labeled neurons. This 
staining was notably rich in the anteroventral, ventrolateral, 
laterodorsal, and ventroposterior nuclei, and zona incerta 
(Fig. 3 C and D). Less numerous but yet considerable abel- 
ing was present in the mediodorsal, parafascicular, entope- 
duncular, lateral posterior, posterior, ventromedial and 
dorsal ateral geniculate nuclei. Staining was weak or absent 
in the central medial, reticular, paraventricular nd most 
medial thalamic regions. In general, it should be noted that 
the appearance of labeled cells within the various thalamic 
nuclei was subject o a consistent intranuclear arrangement 
with regard to the organization of cholinergic input to the 
thalamus. 
Moderate numbers of specifically labeled neurons were 
present in the anterior hypothalamic area, the ventromedial 
hypothalamic nucleus, suprachiasmatic nucleus, and lateral 
hypothalamic area. 
Mesencephalon. Immunoreactivity to M35 at midbrain lev- 
els was observed in pars compacta nd reticulata of the 
substantia nigra, the red nucleus and scattered over dorsal 
and ventral midbrain tegmental regions. Likewise a loose 
pattern of labeled neurons was present in the superior colli- 
culus and periaqueductal grey. Only a few labeled cells were 
detected in the dorsal raph6 nucleus and interpeduncular 
nucleus. 
Electron microscopic observations 
For a more complete understanding of the character of 
the labeling observed under LM conditions, an ultrastruc- 
rural analysis of subcellular distribution of immunoprecipi- 
tate with M35 was carried out for some of the cell groups 
described above. In the scope of the present paper we will 
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Fig. 3. A Photomicrograph of immunoprecipitate in tentative cho- 
linoceptive interneurons in the stratum oriens of the cornu ammon- 
is field 1 in the dorsal aspects of the hippocampus. B Pattern of 
M35 immunoreactivity n the fascia dentata. Note dense staining 
of nerve cells in the hilus and granule cell layer with dense dendrite 
networks in the hilus and those extending into he FD molecular 
layer (compare to Fig. 4). C Low power micrograph of immunola- 
beling with mAChR antibody M35 in the th~,tamus and D, higher 
magnification of the same section taken from the ventrolateral 
thalamic nucleus. Scale bar in A and D = 25 ~tm, in B = 50 gm and 
in C = 500 gm 
describe the immuno-EM precipitate pattern exemplified 
mainly on neocortical layer 5 pyramidal  neurons. An exten- 
sive ultrastructural nalysis of immunoprecipitat ion with 
M35 will be reported in a separate paper. 
F rom LM observations, it already became clear that 
the intracellular precipitate was not uniformly distributed 
over the cytoplasm (Fig. 1 A and C). In most cases the pat- 
tern of immunoreactivity in the cell soma could be charac- 
terized by an irregular patch-like arrangement over the cy- 
toplasm, whereas the nucleus remained unstained. EM ob- 
servations revealed that this irregular cytoplasmic staining 
is not the result of an incomplete penetration of antibodies, 
but probably represents a highly specific staining of muscar- 
inic receptor proteins at a specific stage of  synthesis or 
membrane incorporation. It was a striking observation that 
binding of M35 did not occur in the neuron's endoplasmic 
reticulum, suggesting that the antigenic determinants are 
not expressed in the early phase of formation of polypeptide 
chains. Patches of immunoreactivity in most cases observed 
can be associated with the cell's Golgi apparatus and were 
present on the exterior side in the membrane pouches or 
vesicles (Fig. 5 A and B). This specific pattern of immunore- 
activity possibly indicates binding of M35 either to epitopes 
on the receptor protein becoming recognizable in the final 
stages of protein synthesis. Another explanation may be 
that in the Golgi apparatus the proteins are incorporated 
in membrane fragments, where the receptor proteins are 
molded into their receptor-specific configuration (Lind- 
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Fig. 4A-C. Photomicrographs of M35 immunoprecipitate in the 
hippocampus CA1 (A), CA2 (B) and fascia dentata (FD) (C) of 
the dorsal hippocampus. Labeled neurons were observed in stratum 
oriens, pyramidal cell layers and hilus-granular layer of FD. Prob- 
ably non-pyramidal cells were positively reacting in or adjacent 
to the pyramidal cell layers in CA/ and in the transition zone 
of stratum radiatum and lacunosum-moleculare of CAl. High 
numbers of immunoreactive pyramidal cells are present in CA~4. 
Cresyl violet counterstained. Scale bar in A-C = 50 gm 
strom 1986). Further EM analysis is being currently per- 
formed to reveal this matter. In the soma membrane of 
pyramidal  neurons, immunoprecipitate was occasionally 
observed in a postsynaptic posit ion apposing presynaptic 
terminal boutons indicating axo-somatic synaptic ontacts. 
F rom the cell body, the immunoreactivity could be fol- 
lowed into the basal and apical dendrites, sometimes in 
close proximity to a Golgi complex extending into the den- 
drite. Immunoreactivity o M35 through the entire apical 
and basal dendritic tree could be observed in association 
with the cytoskeleton. The immunoprecipitate possibly rep- 
resents labeled receptor protein aggregates or proteins in- 
corporated in small vesicular structures being transported 
from the site of synthesis in the cell-body to the peripheral 
membrane posit ion where the receptor proteins exert their 
biological function. It is noteworthy that postsynaptic 
membrane labeling with M35 was scarce in the proximal 
main trunk of  the apical dendrites where they traverse layer 
4. This pattern changes in layers 3 and especially in layers 
2 and 1. Here, one could observe considerable branching 
of dendritic material and at the same time gradually increas- 
Fig. 5A-G. Pattern of M35 immunoreactivity at the ultrastructural 
level. A Shows the characteristic distribution of immunoprecipitate 
in the cytoplasm in this case in a layer 5 pyramidal cell. Immuno- 
precipitate in all cases studied was always rich in close proximity 
to the cell's Golgi apparatus (arrow), whereas there is a conspicuous 
lack of labeling in or near to the endoplasmic reticulum (ER). 
B Labeling pattern comparable to that in A in a pyramidal cell's 
apex extending the proximal part of the main shaft of the apical 
dendrite. Again M35 immunoprecipitate in the immediate vicinity 
of the Golgi apparatus and lack of staining in the ER. C Typical 
pattern of tentative transport of immunolabeled mAChR in the 
major branches of basal and apical dendrites of neocortical pyrami- 
dal neurons. D Pattern of cytoplasmic distribution of M35 reactivi- 
ty in a layer 2 non-pyramidal cell. E-G Examples of distal peripher- 
al dendritic profiles provided with immunoreactivity in the postsyn- 
aptic cytoplasm and in high density postsynaptic membrane posi- 
tions (arrows); compare to the non-labeled postsynaptic mem- 
branes indicated by double arrow. Scale bar in A, B and D = 1 gm; 
in C=0.5 gm and in E--G=200 nm 
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ing numbers of postsynaptic membrane labeling going from 
proximal to distal dendritic profiles (Fig. 5C and E-G). 
In all cases labeling within the dendritic cytoplasm could 
be observed in conjunction with labeling at synaptic mem- 
brane sites. The pattern of labeling appeared specific for 
non-spinous pyramidal neurons limited to soma and den- 
dritic cytoplasm and membrane, indicating receptor protein 
presence in conjunction with a cholinoceptive function. 
Discussion 
Immunoreactivity of M35, muscarinic ligand binding 
and cholinergic nnervation 
The present paper eports on immunocytochemical applica- 
tion in the mammalian brain of a monoclonal antibody 
to purified muscarinic receptor proteins. Immunoreactivity 
at the LM level was present in neuronal cell bodies and 
their dendrites as well as in a number of astrocytes mainly 
in cortical and hippocampal areas. EM observations on 
individual labeled neurons upport he view that M35 binds 
to antigenic determinants on muscarinic receptor proteins 
from early stages of synthesis near the Golgi apparatus 
in the soma cytoplasm, through stages of transport me- 
diated by the dendritic microtubular system, to positions 
at the inner surface of the postsynaptic membrane. As such, 
the labeled neurons stained with M35 appear to represent 
a population of cholinoceptive neurons employing muscar- 
inic receptors in their synaptic transmission. A comparison 
of the presently found pattern of immunostained neurons 
will be made with current data on cholinergic innervation 
patterns with data from muscarinic receptor-specific ligand 
autoradiography and with distribution studies of muscar- 
inic receptor mRNAs. 
Cortex. In the cortex there is a striking coincidence between 
the pattern of cholinergic innervation and the immunopreci- 
pitate of M35 to muscarinic receptors. This pattern is nota- 
bly clear e.g. in the visual cortex (Parnavelas et al. 1986) 
and parietal somatosensory cortex (Eckenstein et al. 1988; 
Houser et al. 1985; Lysakowski et al. 1989) where a distinct 
laminar pattern of immunoreactivity to choline acetyltrans- 
ferase (CHAT) has been demonstrated. ChAT-positive 
fibers and terminals have a high density in layers 1 and 
2, slightly less in layer 3, lowest in layer 4, higher in layer 
5 and with medium density in layer 6. In line with the 
preponderant on-spinous presence of M35 immunoreac- 
tivity, the presynaptic mmunolabeling with ChAT was lo- 
calized in endings on dendritic shafts and only rarely on 
soma membranes or on dendritic spines (Dolabela de Lima 
and Singer 1986; Houser et al. 1985). The laminar cortical 
innervation pattern relates very well with the distribution 
of M35 immunoreactivity, suggesting a match between pre- 
synaptic ChAT and postsynaptic mAChR staining. More- 
over, the same pattern of dominance of innervation i  layers 
1/2 and layer 5 was demonstrated with anterograde tracing 
from the magnocellular basal nucleus, which is the source 
of extrinsic cholinergic input from the basal forebrain to 
the neocortex (Luiten et al. 1987; Spencer et al. 1985). 
The pattern of M35 immunoreactive n urons over the 
neocortical layers also corresponds to the laminar distribu- 
tion of cholinoceptive neurons as established by electro- 
physiological methods (Lamour and Dykes 1988; Lamour 
et al. ]982). With these methods the highest percentage of 
acetylcholine-sensitive neurons were recorded in layer 5 
with only moderate numbers in layers 2/3 and 6. 
Autoradiographic detection of radiolabeled ligands to 
muscarinic receptors in the cortical mantle for a large part 
agrees well with M35 binding. Most ligand binding studies 
indicate high concentrations of predominantly M1 type 
muscarinic receptors in the superficial layers 1-3 of the neo- 
cortex (Cort6s et al. 1987; Frey et al. 1985; Kuhar and Ya- 
mamura 1976; Mash and Potter 1986; Rotter et al. 1979; 
Spencer et al. 1986; Vogt 1988) and layer 6. Other investiga- 
tions, however, indicate low muscarinic binding levels in 
layers 4 and 5, both for specific M1 receptors (Mash and 
Potter 1986; Spencer et al. 1986) and for mAChR in general 
(Cort6s et al. 1987; Frey et al. 1985; Rotter et al. 1979). 
On the other hand, Spencer et al. (1986) and Mash and 
Potter (1986) who studied distribution of M2 receptor-spe- 
cific ligands, report relatively high binding in layer 5, which 
is supported by findings in the human cortex (Vogt 1988). 
Hippocampus. In the hippocampus, M35 immunoreactivity 
appears to be well related to cholinergic innervation path- 
ways originating from the medial septum-diagonal band 
cholinergic ell groups (Geneser 1987; Houser et al. 1983; 
Nyakas etal. 1987; Storm-Mathisen 1970). This pattern 
can be summarized as stratified projections to stratum or- 
iens, pyramidale and the lacunosum-moleculare transition 
to radiatum of the cornu ammonis (CA). Projections to 
the fascia dentata (FD) are to the molecular layer, supra- 
granular layer and the polymorphic layer of the hilus 
(Brady and Vaughn 1988; Frotscher and L&/mth 1985; 
Geneser 1987; Houser etal. 1983; Nyakas etal. 1987; 
Storm-Mathisen 1970). M35 labeling of cell bodies was lo- 
calized in stratum pyramidale and oriens of the CA and 
in the granular layer and hilar region of the FD with charac- 
teristic labeling of dendrites in stratum radiatum and mole- 
culare. M35 in the molecular layer of the FD had a clear 
affinity to the apical dendrites of several cell types in and 
adjacent to the stratum granulosum. However, not all cells 
of the granular layer reacted immunopositive. In the hippo- 
campus proper, both pyramidal (especially in CA3) and 
non-pyramidal cells such as multipolar and fusiform inter- 
neurons in oriens, radiatum and hilus were found immuno- 
reactive for M35. The putative cholinoceptive character of 
these categories of neurons corroborates the heterogeneity 
of hippocampal neurons receiving a cholinergic input 
(Frotscher and L6rfinth 1986). 
Non-selective muscarinic ligands were found to bind all 
over the hippocampal formation with highest densities in 
stratum oriens and radiatum of CA and molecular layer 
of FD (Cort6s et al. 1987; Frey et al. 1985; Kuhar and 
Yamamura 1976; Mash and Potter 1986; Rotter et al. 1979; 
Spencer et al. ] 986). However, labeling with subtype-specif- 
ic muscarinic antagonists (Mash and Potter 1986; Spencer 
et al. 1986) indicate that the hippocampus i dominated 
by M1 receptors, but that localized M2 receptors are pres- 
ent in the pyramidal cell layer and the polymorphic layer 
of the hilus (Mash and Potter 1986). 
Amygdala. mAChR-immunolabeling with M35 in the 
amygdaloid body could be characterized by intensely 
stained cells in the central nucleus and medium dense stain- 
ing in lateral and basolateral nuclei. This pattern does not 
fully match the pattern of cholinergic innervation which 
is dominated by a heavy basal forebrain projection to the 
483 
basolateral nucleus (Carlsen et al. 1985; K~tsa 1986; Luiten 
et al. 1987), whereas the medial part of the central nucleus 
only displays moderate acetylcholinesterase (AChE)-activi- 
ty. This apparent discrepancy between M35 cell labeling 
and presynaptic labeling with cholinergic markers, however, 
may be partly elucidated by ultrastructural nalysis. Im- 
muno-EM study showed dense cytoplasmic staining of cen- 
tral amygdaloid neurons, but very sparse labeling of post- 
synaptic membrane sites in this amygdaloid nucleus. Con- 
versely, the labeling pattern in the basolateral nucleus was 
characterized by only moderate to light immunoreactivity 
in soma and dendrites, but high frequency labeling in den- 
dritic membranes facing presynaptic endings (unpublished 
observations). Most autoradiographic l gand binding stu- 
dies indicate the presence of mAChR in several amygdaloid 
subregions, both of the M1 and the M2 receptor type with 
relatively highest densities in the lateral cell groups. High 
levels of M1 labeling have been reported for the medial 
nucleus (Mash and Potter 1986; Spencer et al. 1986). 
Basal ganglia. M35 immunoreactivity in the basal ganglia 
showed a rather differential appearance, not typical of that 
found in other brain regions. Some cells scattered over the 
caudate-putamen and clustered in its ventrolateral spects 
stained ense with M35. The majority of the cells, however, 
showed only a light immunopositive r action. Conversely, 
in the globus pallidus fewer cells were stained, but more 
strongly. Ostensibly, this basal ganglia pattern of M35 im- 
munoprecipitate does not match very well with the repor- 
tedly high levels of the cholinergic marker enzymes ChAT 
and AChE (Houser et al. 1983; Kfisa 1986) nor with the 
very high affinity binding of ligands for mAChR and its 
subtypes M1 and M2 (Cortts et al. 1987; Mash and Potter 
1986; Rotter et al. 1979 ; Spencer et al. 1986). Preliminary 
immuno-EM investigation of lightly stained striatal neu- 
rons, however, indicate the localized presence of immuno- 
precipitate in the cytoplasm, dendritic transport system and 
postsynaptic dendritic membranes. A possible explanation 
of light staining under LM observation may be that a light 
immunoreaction corresponds to relatively low concentra- 
tions of receptor proteins in the cytoplasm and low levels 
of protein storage, especially in neurons that are very active 
in cholinoceptive synaptic processing. 
Thalamus. The thalamic nuclei displayed a very rich pres- 
ence of immunoreactivity after M35 application. Although 
individual neurons and their dendrites howed medium- 
density staining, the number of labeled cells was very high 
in various thalamic nuclei. The thalamus as a whole receives 
a vast and widespread cholinergic input (Hallanger and 
Wainer 1988; Henderson 1987; Kflsa 1986). Recent studies 
combining retrograde intraaxonal transport and ChAT im- 
munocytochemistry clearly indicate massive cholinergic 
projections to a variety of thalamic nuclei originating from 
cholinergic sources in both basal forebrain (magnocellular 
basal nucleus, diagonal band nuclei) and brainstem (pedun- 
culopontine tegmental nucleus and latero-dorsal tegmental 
nucleus) (Hallanger et al. 1987; Kfisa 1986; Par6 et al. 1988; 
Woolf and Butcher 1986). 
Binding of ligands to mAChR in the thalamus was re- 
ported by several investigators and is very intense in the 
anteroventral, nterodorsal, anteromedial nd lateroposter- 
ior nuclei, but considerable in most other thalamic nuclei 
as well (Cortts et al. 1987; Mash and Potter 1986; Spencer 
et al. 1986). More recent studies employing selective ligands 
indicate that most of these receptors are of the M2 type 
(Mash and Potter 1986; Spencer et al. 1986). 
Muscarinic receptor recognition with immunocytochemistry 
From the comparisons made between M35 immunoreactivi- 
ty, autoradiographic detection of mAChR and cholinergic 
innervation as described above for several regions of the 
forebrain, a pattern emerges howing a considerable degree 
of overlap. Deviations from this basic pattern of cholinergic 
synaptic organization system may be attributed to a variety 
of possible causes. A major point of discussion refers to 
the binding of M35, some of which relate to immunocyto- 
chemical detection of receptor proteins in general, and some 
to muscarinic receptor proteins in particular. Although only 
a limited number of investigations report on immunocyto- 
chemical labeling of receptors (or receptor proteins) they 
have a few characteristics in common that appear specific 
for dealing with receptor proteins. First, as in the present 
study, staining of receptors has been localized in postsynap- 
tic membrane positions (Goldsmith et al. 1979; Lentz and 
Chester 1977; Nghiem etal. 1983; Sealock etal. 1984; 
Triller et al. 1985; Van den Pol and Gorcs 1988) in most 
cases. In our EM-analysis only occasional presynaptic label- 
ing in the cerebral cortex was observed, similarly to the 
results of Aoki et al. (1987), who worked with fl-adrenergic 
receptors. Continued immuno-EM investigation employing 
more sensitive antibody penetration methods are now in 
progress to approach this question. Second, several studies 
on immunocytochemical detection of receptor proteins indi- 
cate a relatively sensitive character of receptor proteins. 
This sensitivity is expressed as susceptibility in staining for 
fluctuations in immunocytochemical procedures (Deutch 
et al. 1987; this study). Various studies also report heteroge- 
neous sensitivity of antibody binding in different parts of 
the brain. For example, it was noted by van den Pol and 
Gorcs (1988) that antibodies to glycine receptors bind 
strongly in spinal cord and lower brainstem, but only lightly 
in hippocampus and parts of the olfactory bulb. Antibodies 
to nicotinic receptor proteins are also reported to show 
heterogeneous affinity to different cell groups (Deutch et al. 
1987). Differential staining and susceptibility may be due 
to a large number of causes. One reason may simply be 
technical: tissue penetration of antibodies and accessibility 
and recognition of the antigen. In the case of receptor stain- 
ing, however, we should realize the highly dynamic nature 
of receptors being subject to complex and multifarious 
mechanisms of regulation (Liles and Nathanson 1986; 
Nathanson 1982; Raposo et al. 1987). Receptor proteins 
may be present in different concentrations within the cell 
possibly as a function of their rate of turnover. It is not 
unlikely that neurons very active in cholinergic synaptic 
transduction (associated with high AChE activity) may ex- 
hibit lower levels of mAChR protein storage than less active 
cells. In the present study we have seen several examples 
which may support this assumption e.g. light staining of 
cells in the caudate-putamen vs. more dense staining in the 
globus pallidus and heavy precipitate in central amygdala 
vs. a lighter staining in the basolateral mygdala. 
Differential staining with M35 to mAChR, furthermore, 
may indicate differences in affinity to the various muscar- 
inic receptor subpopulations. There is ample documenta- 
tion for a pharmacological classification i  two (M1, M2) 
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(Hammer et al. 1980) or three (M1-3) (Doods et al. 1987; 
Waelbroeck et al. 1986; Waelbroeck et al. 1987) muscarinic 
receptor subclasses based on differences in affinity for re- 
ceptor ligands. More recent molecular studies, employing 
methods of cloning and protein sequence analysis, however, 
revealed four distinct but highly homologous gene products 
designated as HMI -4  for the human receptors (Peralta 
et al. 1987a and b) and as ml ,  m3 and m4 (and even m5 
(Bonner et al. 1988)) for rat muscarinic receptors and m2 
for a human receptor by Bonner et al. (1987). Recently, 
Buckley et al. (1988) reported the distribution of oligonuc- 
leotide probes for the above mentioned mlm4 muscarinic 
receptors in rat brain by in situ hybridization techniques. 
It may be concluded from that study that their ml ,  m3 
and m4 probes hybridize with structures predominantly in
cortex, hippocampus, olfactory regions and basal ganglia 
collectively corresponding to the distribution of the phar- 
macological M1 binding sites. Localization of single sub- 
type probes, for example in the basal lateral amygdala nd 
the granular layer of the fascia dentata (ml-subtype), the 
medial septum and diagonal band (m2-subtype), the lateral 
septal nucleus, central gray and superior colliculus (m3- 
subtype) suggests that M35 potentially may recognize most 
muscarinic subtypes. 
It may be clear from the foregoing description of M35 
binding and its possible significance for mAChR study that 
a large number of questions remain to be addressed in 
greater detail. Currently, our continued interest is focussed 
on further combined LM and EM analysis of M35 immuno- 
reactive neurons and synaptic membrane-binding distribu- 
tion in various brain regions. Addit ional  evidence for the 
binding nature of M35 may come from double-label im- 
munocytochemistry combining M35 postsynaptic labeling 
and specific cholinergic presynaptic markers uch as CHAT, 
ganglioside chol-1 and anterogradely transported tracers 
(Borroni et al. 1987; Dolabela de Lima and Singer 1986; 
Eckenstein et al. 1988; Frotscher and L6rfinth 1985; Luiten 
et al. 1987, 1988). 
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